Idiopathic Hypersomnia Ih clinical trials

Explore recruiting idiopathic hypersomnia ih clinical trials.

Recruiting idiopathic hypersomnia ih studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Idiopathic Hypersomnia Ih trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia

Italy, Belgium, Czechia, France, Netherlands, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Dose-Finding, Adaptive, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with Idiopathic Hypersomnia (IH)

Italy, France, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Idiopathic Hypersomnia Ih trials by city

Idiopathic Hypersomnia Ih clinical trials

Recruiting idiopathic hypersomnia ih studies right now

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

Also recruiting in Europe

A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia

A Dose-Finding, Adaptive, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with Idiopathic Hypersomnia (IH)

Idiopathic Hypersomnia Ih trials by city

Other conditions